LY4167586 for Obesity or Overweight with Type 2 Diabetes

A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes

Recruiting Phase 1 Interventional Study
Obesity Overweight Diabetes Mellitus, Type 2
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
617 (estimated)
Sponsor
Eli Lilly and Company · Industry
Who this trial is looking for

This trial is looking for people with obesity or overweight, with or without Type 2 Diabetes, to test the safety of a new treatment called LY4167586. Participants will stay in a research unit for several nights over about 53 to 89 weeks.

Are You a Good Fit for This Trial?
Must be taking Metformin

You may be able to join if

  • I am at least 21 years old.
  • I have had a stable weight for the last 3 months.
  • I have a BMI of 30 or higher, or a BMI of 27 and have certain weight-related health issues.
  • I have a BMI of 25 or higher and have Type 2 Diabetes for at least 6 months.
  • I control my diabetes with diet and exercise or a stable dose of metformin.

You may not be able to join if

  • I have a serious history or current issues with my heart, lungs, liver, kidneys, gastrointestinal system, hormones (except Type 2 Diabetes), blood, or nervous system.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The main purpose of this study is to look at how safe and well-tolerated LY4167586 is in participants with obesity or overweight with or without Type 2 Diabetes. Blood tests will be performed to check how much LY4167586 gets into the bloodstream and how long it takes the body to eliminate it following a single administration. Participation in the study will last between approximately 53 to 89 wee…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Participants must be 21 in Singapore. * Have had a self-reported stable weight for 3 months prior to screening (less than approximately 5 percent (%) body weight change. Part A, B, D, and E * Have a body mass index (BMI) of greater than or equal to 30 kilograms per square me…
Contacts

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or

1-317-615-4559

LillyTrials@Lilly.com

CONTACT

Physicians interested in becoming principal investigators please contact

clinical_inquiry_hub@lilly.com

CONTACT